GlycanAge
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$52.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlycanAge is a biotech company that provides a biological age test designed to discover, measure, and optimize longevity by analyzing glycan biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycanAge Comparables
Compare GlycanAge with similar companies based on industry and business-model similarity.
GlycanAge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Seed | Feb 19, 2024 |
Key People
Founding team and executive leadership
GlycanAge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LaunchHub Ventures | Series A |
| Lightfield Equity | Series A |
| South Central Ventures | Series A |
| BrightCap Ventures | Series A |
| Vesna Deep Tech Fund | Series A |
| Guinness Ventures | Series A |
| Kadmos Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$9M round closed
GlycanAge Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GlycanAge's valuation, stock price, and market status.